0

Global Injectable Drugs Market 2017-2021

  • Published: Jul 2017
  • Pages: 84
  • SKU: IRTNTR13955
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

This market research study identifies AbbVie, F. Hoffmann-La Roche, GlaxoSmithKline, and Sanofi as the leading players in the global injectable drugs market. A comprehensive analysis of this market is also presented by molecule type (biologics and small molecules) and by geography (the Americas, APAC, and EMEA).

Overview of the global injectable drugs market

According to Technavio’s market research report, the global injectable drugs market will grow at a CAGR of more than 8% during the forecast period. The rising demand for self-injection devices is one of the key drivers that will be responsible for the market’s growth during the estimated period. The high demand for diabetes and other hormone replacement therapies is boosting the adoption of self-injection devices on a global level. Currently, the largest number of diabetes patients is witnessed in countries such as China, India, and the US. The lack of awareness and treatment facilities in the African region is responsible for the growing number of new diabetic cases. The adoption of self-injectable devices will continue to increase among the group of people that rely on a daily dose of insulin. This will positively influence the growth of the global injectable drugs market.

One of the key trends that will gain  traction in the market in the coming years is the entry of novel vaccines. The rising focus on the prevention and treatment of diseases such as cancer, hepatitis infection, HIV infection, and severe acute respiratory syndrome has resulted in the introduction of new therapeutic vaccines. Additionally, advancements of technology also led to the introduction of innovative vaccines such as dendritic cell vaccines, DNA vaccines, T-cell receptor peptide vaccines, and recombinant vector vaccines.

Competitive landscape and key vendors

The injectable drugs market is characterized by the presence of many companies. These vendors are increasingly competing against each other based on factors such as aggressive pricing, product efficacy, limited side effects, rich pipeline, and operational base. The advent of biosimilars, advancement in research activities, and the launch of novel therapies will strengthen the competitive environment of this marketspace.

Key vendors in this market are -

  • AbbVie
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Sanofi

Other prominent vendors in the market include Bayer, Bristol-Myers Squibb, Merck, Takeda Pharmaceutical, and Teva Pharmaceutical.

Segmentation by molecule type and analysis of the injectable drugs market

  • Biologics
  • Small molecules

The rising inclination towards targeted therapies and personalized medicines is contributing to the high growth of biologics. Biologic products are used to treat diseases like cancer and autoimmune disorders such as Crohn’s disease and multiple sclerosis. The biologics segment will continue to gain popularity during the next few years due to the combination of biopharmaceutical production and advanced bioengineering.

Segmentation by geography and analysis of the injectable drugs market

  • Americas
  • APAC
  • EME

The adoption of injectable medications in the US is driven by the increasing investments in the healthcare segment and the rising investment in research and developmental activities, especially in the oncology sector. The market will continue to grow in the Americas during the next few years due to the increasing prevalence rate of diseases such as cancer, autoimmune disorders, and hormonal disorders.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2021?
  • What are the key factors driving the global injectable drugs market?
  • What are the key market trends impacting the growth of the global injectable drugs market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global injectable drugs market?
  • What are the market opportunities and threats faced by the vendors in the global injectable drugs market?
  • What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
  • What are the key outcomes of the five forces analysis of the global injectable drugs market?

Technavio also offers customization on reports based on specific client requirement

 

Read More Read Less

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline
  • ROA

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Pipeline landscape

PART 07: Market segmentation by molecule type

  • Biologics
  • Small molecules

PART 08: Geographical segmentation

  • Injectable drugs market in Americas
  • Injectable drugs market in EMEA
  • Injectable drugs market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges

  • Market drivers
  • Market challenges

PART 11: Market trends

  • Rising awareness leading to high demand for injectable drugs
  • Increase in industry-academia collaboration
  • Expected entry of novel vaccines
  • Advent of biosimilars

PART 12: Vendor landscape

  • Competitive landscape

PART 13: Key vendor analysis

  • AbbVie
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Sanofi
  • Other prominent vendors

PART 14: Appendix

  • List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Report
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>